Fesupplix Kaul

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 27, 2022
Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors.

Sho Hasegawa, Noritoshi Kobayashi, Damian Wild

Pageof 1

Frequent Collaborators

1 joint publications

Damian Wild

1 joint publications

Atsushi Nakajima